Stephens Inc. AR Purchases 299 Shares of Intuitive Surgical, Inc. $ISRG

Stephens Inc. AR raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,073 shares of the medical equipment provider’s stock after purchasing an additional 299 shares during the quarter. Stephens Inc. AR’s holdings in Intuitive Surgical were worth $4,930,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in ISRG. Chilton Capital Management LLC grew its stake in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. purchased a new position in Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA purchased a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. TD Capital Management LLC lifted its holdings in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares in the last quarter. Finally, 1248 Management LLC purchased a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ISRG. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. BTIG Research lowered their price target on shares of Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating on the stock in a report on Monday, October 13th. Zacks Research downgraded shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. UBS Group set a $529.00 price target on shares of Intuitive Surgical in a report on Monday, October 13th. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Fifteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $585.05.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $462.74 on Wednesday. The firm has a fifty day moving average price of $454.39 and a 200 day moving average price of $495.58. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a market cap of $165.88 billion, a price-to-earnings ratio of 64.54, a P/E/G ratio of 4.81 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the business earned $1.84 earnings per share. Intuitive Surgical’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the sale, the director owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.